Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Firefighters, States, Struggle To Find Replacements for Toxic Foam September 9, 2021 Irvin Jackson Add Your Comments For decades, fire departments and military bases have used firefighting foam to fight petroleum fires, which cannot be combatted with water alone. However, as more evidence links toxic chemicals in the aqueous film-forming foam (AFFF) to cancer and other health risks, finding an adequate replacement has become a struggle. Versions of AFFF used during training and response exercises in recent decades contained per- and polyfluoroalkyl substances (PFAS), which can persist in the environment and human body for decades. Commonly referred to as “forever chemicals,” these substances have been linked to a number of serious health risks and are now being detected in the water and soil around military bases, airports and other firefighter training sites nationwide. As information about the long-term risks of firefighting foam are being recognized, there has been a struggle to find a replacement foam to battle petroleum and fuel fires, which won’t just cause a different type of contamination or health risk. Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Firefighting Foam Lawsuits Were you or a loved one exposed to toxic AFFF Chemicals? Lawyers are reviewing aqueous film forming foam (AFFF) lawsuits for firefighters, military personnel and individuals who developed cancer or other health issues from exposure to toxic firefighting foam chemicals. Learn More SEE IF YOU QUALIFY FOR COMPENSATION One state at the forefront of this struggle is Massachusetts, where last year a PFAS Interagency Task Force was created involving members of the legislature. The goal of the task force is to look into ways the state can address PFAS contamination, including future prevention. The task force’s findings are due by December 31, but various media reports in recent days have warned that the task force is struggling with the aspect of finding suitable replacements for AFFFs. The state’s Department of Fire Services has scheduled a seminar for September 13, this coming Monday, including a discussion of replacing AFFFs with something new, but it is unclear what that new substance would be and how they could afford the change, according to various reports. Last week, state fire officials told the task force that foam is the only tool usable for fighting flammable liquid fires. They come in three classes: long-chain foams, C6 or short-chain foams, and fluorine-free foams. Some departments had tried switching to short-chain foams, but they contain fluorine, which carries its own set of health and environmental risks. That leaves fluorine-free foams, which are still very new, expensive, and would require storage tanks to be cleaned, and the purchasing of new equipment to apply it in firefighting, which could only be done at significant financial cost. However, the problem is one likely to be faced by firefighting groups and the military in coming years, as numerous communities have discovered the risks of AFFF and are now suffering drinking water contamination. In addition, a growing number of firefighters are being diagnosed with various forms of cancer following long-term exposure to the older AFFF foam products. PFAS Health Concerns PFAS were first introduced into the manufacturing industry in the 1940’s, because of their ability to resist heat, grease, stains, and water. However, since then the chemicals have been linked to a myriad of adverse health effects including liver damage, thyroid disease, decreased fertility, high cholesterol, obesity, hormone suppression, and cancer. The chemicals are projected to take thousands of years to degrade, and past studies have shown their ability to enter and stay in the environment and human body through the air, dust, food, soil, and water. Previous U.S. Centers for Disease Control and Prevention studies have shown PFAS chemicals primarily settle into the blood, kidney and liver, and could likely be detected in the blood of 98% of the U.S. population. A number of chemical manufacturers face a growing number of PFAS firefighter foam lawsuits in federal courts nationwide, which are centralized in the U.S. District Court for the District of South Carolina for pretrial proceedings. Plaintiffs say exposure to the chemicals have led to cases of cancer among military and civilian firefighters, and among those who live in communities whose water supplies have been contaminated. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Cancer, Chemicals, Fire, Firefighting Foam, Flourine, PFAS, Water Contamination Find Out If You Qualify for A AFFF Lawsuit Settlement More Firefighting Foam Lawsuit Stories Three AFFF Ulcerative Colitis Lawsuits Selected for Tier 2 Bellwether Trials September 16, 2025 Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025 PFAS Water Contamination Map Shows States With Highest ‘Forever Chemicals’ August 22, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Firefighter Turnout Gear Lawsuits Belong in MDL With Other AFFF and PFAS Exposure Lawsuits, Judge Indicates August 28, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)